Here’s What Pushed Crispr Therapeutics AG Up 23.6% in December – Motley Fool
Dispatch Tribunal |
Here's What Pushed Crispr Therapeutics AG Up 23.6% in December
Motley Fool Shares of Crispr Therapeutics AG (NASDAQ:CRSP), a biotech start-up named after the promising new gene-editing technology it's focused on, bounded 23.6% higher in December, according to data from S&P Global Market Intelligence. A new collaboration deal … CRISPR Therapeutics Announces Proposed Public Offering of … A Comparison of Top Movers: Overstock.com, Inc. (OSTK), CRISPR Therapeutics AG (CRSP) Crispr Therapeutics (CRSP) Lifted to “Buy” at BidaskClub |
